April 23, 2026
Endlyz Therapeutics
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.
- Round
- Seed
- Amount raised
- $17.3M
- Lead investor
- Michael J. Fox Foundation
- Industry
- Biotechnology
- Headquarters
- Boston, United States
- Employees
- 1-10
- Website
- www.endlyz.com
- View profile →
Source: Crunchbase snapshot 2026-05-15